About MyVHL: Patient Natural History Study

About MyVHL

We Promise

Frequently Asked Questions

Contact Us


MyVHL is available in English and Spanish. You can choose your preferred language when you register.

About MyVHL

The MyVHL: Patient Natural History Study is collecting information about von Hippel-Lindau (VHL), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), Birt-Hogg-Dubé (BHD), Succinate Dehydrogenase Complex Subunit B (SDHB) and other related conditions in hopes of finding a cure for these diseases as well as related kidney and adrenal tumors. Learning about their similarities and differences will help scientists understand how these genes work in the cell, and how we might intervene and make a difference.

Von Hippel-Lindau (VHL) is a disease which causes tumors in multiple parts of the body. Since the discovery of the VHL gene in 1993, progress has been made in understanding the processes within the cell governed by the VHL gene. The series of processes (or pathways) controlled by VHL also include the genes for Birt-Hogg-Dubé (BHD), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), and Succinate Dehydrogenase Complex Subunit B (SDHB), three other genetic kidney cancer syndromes. Drugs to assist in management of these diseases are beginning to emerge and will need to go through clinical trials to evaluate their effectiveness.

 These diseases are rare, which makes it difficult to gather information and develop treatments. The MyVHL: Patient Natural History Study will collect information from patients all over the world and could help researchers have a better understanding of VHL and associated diseases. The rarity of these diseases makes it difficult to conduct large clinical trials. To address these deficiencies, the VHL Alliance, in collaboration with the National Organization for Rare Disorders (NORD), has developed a patient databank to collect detailed medical information on patients with VHL, BHD, HLRCC, SDHB and related tumors, to help discover possible factors contributing to disease pathogenesis/progression, and to help evaluate efficacy of novel therapies.

 For more information, visit: vhl.org/MyVHL.

Top of Page


We Promise

By participating in the MyVHL: Patient Natural History Study, you become part of a community created to energize, inform, engage and support VHL, BHD, and HLRCC research. We come together to help find better treatments, more quickly. When you add your voice, VHLA makes a steadfast promise:

Top of Page


Frequently Asked Questions

Top of Page


Contact Us

If you experience any difficulties with MyVHL, please email: MyVHL@vhl.org or call: 617-277-5667 x4. 

Top of Page